FHTX Insider Trading Activity and SEC Form 4 Filings
FHTX insider trading summary
No open-market insider purchases or sales of Foghorn Therapeutics Inc. (FHTX) have been reported on SEC Form 4 in the past 12 months.
Latest FHTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 23, 2024 | Carlos Costa | Chief People Officer | Sell | $9K (857 @ $10.17) |
| Sep 20, 2024 | Carlos Costa | Chief People Officer | Sell | $359K (35,756 @ $10.04) |
| Sep 18, 2024 | Carlos Costa | Chief People Officer | Sell | $116K (11,574 @ $10.05) |
| Sep 17, 2024 | Carlos Costa | Chief People Officer | Sell | $103K (10,272 @ $10.04) |
| Sep 16, 2024 | Carlos Costa | Chief People Officer | Sell | $4K (400 @ $10.00) |
| Sep 9, 2024 | Steven F. Bellon | Chief Scientific Officer | Sell | $190K (20,000 @ $9.50) |
| Mar 11, 2024 | Fanny Cavalie | Chief Strategy/Bus Ops Officer | Sell | $72K (11,000 @ $6.56) |
| Aug 16, 2023 | Samuel Agresta | Chief Medical Officer | Sell | $2.6M (311,297 @ $8.25) |
| Oct 27, 2020 | Platinum Falcon B 2018 RSC Ltd | Insider | Buy | $2.4M (150,000 @ $16.00) |
| Oct 27, 2020 | Abu Dhabi Investment Authority | Insider | Buy | $2.4M (150,000 @ $16.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.